BACKGROUND/AIM: The inhibition of the mevalonate pathway through genetic defects such as mevalonate kinase deficiency (MKD) or pharmacological drugs such as aminobisphosphonates causes a shortage of intermediate compounds, in particular geranylgeranyl-pyrophosphate (GGPP), which is associated with the consequent augmented IL-1β release in monocytes. Considering that, due to its biochemical structure, isoprenoid geraniol enters the mevalonate pathway and may revert the genetic or pharmacological inhibition, the present study tested isoprenoid geraniol in cellular and animal MKD models obtained through the use of aminobisphosphonate pamidronate. MATERIALS AND METHODS: The effect of natural isoprenoid geraniol on bacterial induced-inflammation was evaluated in a monocytic cell line (Raw 264.7) and in Balb/c mice treated with pamidronate. RESULTS: Geraniol diminished the levels of inflammatory markers induced by pamidronate stimuli in vitro and in vivo. CONCLUSION: Geraniol may be proposed as a novel therapeutic approach for the orphan disease MKD, and may also be considered for the evaluation of possible inflammatory side-effects of aminobisphosphonates.
BACKGROUND/AIM: The inhibition of the mevalonate pathway through genetic defects such as mevalonate kinase deficiency (MKD) or pharmacological drugs such as aminobisphosphonates causes a shortage of intermediate compounds, in particular geranylgeranyl-pyrophosphate (GGPP), which is associated with the consequent augmented IL-1β release in monocytes. Considering that, due to its biochemical structure, isoprenoidgeraniol enters the mevalonate pathway and may revert the genetic or pharmacological inhibition, the present study tested isoprenoidgeraniol in cellular and animal MKD models obtained through the use of aminobisphosphonatepamidronate. MATERIALS AND METHODS: The effect of natural isoprenoidgeraniol on bacterial induced-inflammation was evaluated in a monocytic cell line (Raw 264.7) and in Balb/c mice treated with pamidronate. RESULTS:Geraniol diminished the levels of inflammatory markers induced by pamidronate stimuli in vitro and in vivo. CONCLUSION:Geraniol may be proposed as a novel therapeutic approach for the orphan disease MKD, and may also be considered for the evaluation of possible inflammatory side-effects of aminobisphosphonates.
Authors: Manuella Maria Silva Santos; Carolina Elsztein; Rafael Barros De Souza; Sérgio de Sá Leitão Paiva; Jaqueline Azevêdo Silva; Sergio Crovella; Marcos Antonio De Morais Journal: Curr Genet Date: 2018-01-27 Impact factor: 3.886
Authors: Christine Wittig; Claudia Scheuer; Julia Parakenings; Michael D Menger; Matthias W Laschke Journal: PLoS One Date: 2015-07-08 Impact factor: 3.240
Authors: Marwa Mohamed Atef; Marwa Nagy Emam; Rehab E Abo El Gheit; Eman M Elbeltagi; H A Alshenawy; Doaa A Radwan; Reham L Younis; Rania Nagi Abd-Ellatif Journal: Neurochem Res Date: 2022-03-02 Impact factor: 4.414
Authors: Luigia De Fazio; Enzo Spisni; Elena Cavazza; Antonio Strillacci; Marco Candela; Manuela Centanni; Chiara Ricci; Fernando Rizzello; Massimo Campieri; Maria C Valerii Journal: Front Pharmacol Date: 2016-03-03 Impact factor: 5.810